We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Image: The GenoPredict assay from Predicta Biosciences is available to Tempus Life Sciences partners to support exploratory research and clinical development programs (photo courtesy of Shutterstock)

Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

Tempus AI and Predicta Biosciences announced the commercial expansion of a co-branded whole‑genome sequencing assay. More...
17 Apr 2026
Image: The Content Innovation Engine integrates spatial biology technology with the company’s established expertise in ultra-sensitive, quantitative immunoassay development based on Simoa technology (photo courtesy of Quanterix)

Quanterix Launches Integrated Spatial Biology Platform for Cancer Research

Quanterix will debut its Content Innovation Engine at AACR 2026, unifying spatial biology with ultra-sensitive immunoassay capabilities to support translational and clinical applications. More...
17 Apr 2026
Image: NTU Assoc Prof Y.C. Chen (right) holding the new biochip, which can detect miRNA in 20 minutes using AI, with his PhD student Fu Bowen behind him (left) (photo courtesy of Nanyang Technological University)

AI-Enabled Biochip Detects microRNA Biomarkers in Minutes

An AI-enabled nanophotonic biochip detects multiple microRNAs from blood in 20 minutes, speeding lab workflows. More...
17 Apr 2026
Image: (From left to right) Nizar Bahlis, MD, Holly Lee, MD, Paola Neri, MD, Ph.D. (photo courtesy of Riley Brandt, University of Calgary)

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma

New findings show how myeloma cells adapt following immunotherapy, revealing mechanisms linked to relapse. More...
17 Apr 2026
Image: The assay evaluates multiple cancer‑associated signals together to support risk assessment for early detection (photo credit: Adobe Stock)

Blood Test Detects Early Pancreatic Cancer in High-Risk Patients

A new multi‑signal blood test detects pancreatic cancer earlier in high‑risk patients, 82.6% sensitivity and 97.5% specificity. More...
17 Apr 2026
DB function failed with error number 0

Host–Virus Genetic Interactions Drive Nasopharyngeal Cancer Risk

More...
17 Apr 2026
Image: (From left to right) Nizar Bahlis, MD, Holly Lee, MD, Paola Neri, MD, Ph.D. (photo courtesy of Riley Brandt, University of Calgary)

Tumor Analysis Identifies Protein Changes Driving Bispecific Resistance in Myeloma

New findings show how myeloma cells adapt following immunotherapy, revealing mechanisms linked to relapse. More...
17 Apr 2026
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Copyright © 2000-2026 Globetech Media. All rights reserved.